Effectiveness of low-dose theophylline for the management of biomass-associated COPD (LODOT-BCOPD): study protocol for a randomized controlled trial.

Saved in:
Bibliographic Details
Title: Effectiveness of low-dose theophylline for the management of biomass-associated COPD (LODOT-BCOPD): study protocol for a randomized controlled trial.
Authors: Siddharthan T; Division of Pulmonary and Critical Care, University of Miami, School of Medicine, Johns Hopkins University, 1951 NW 7th Ave, Suite 2308, Miami, FL, 33136, USA. tsiddhar@miami.edu.; Center for Global Non-Communicable Diseases, Johns Hopkins University, Baltimore, USA. tsiddhar@miami.edu., Pollard SL; Division of Pulmonary and Critical Care, University of Miami, School of Medicine, Johns Hopkins University, 1951 NW 7th Ave, Suite 2308, Miami, FL, 33136, USA.; Center for Global Non-Communicable Diseases, Johns Hopkins University, Baltimore, USA., Jackson P; Division of Pulmonary and Critical Care, Virginia Commonwealth University, Richmond, USA., Robertson NM; Division of Pulmonary and Critical Care, University of Miami, School of Medicine, Johns Hopkins University, 1951 NW 7th Ave, Suite 2308, Miami, FL, 33136, USA.; Center for Global Non-Communicable Diseases, Johns Hopkins University, Baltimore, USA., Wosu AC; Center for Global Non-Communicable Diseases, Johns Hopkins University, Baltimore, USA.; Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, USA., Rahman N; Division of Pulmonary and Critical Care, University of Miami, School of Medicine, Johns Hopkins University, 1951 NW 7th Ave, Suite 2308, Miami, FL, 33136, USA.; Center for Global Non-Communicable Diseases, Johns Hopkins University, Baltimore, USA., Padalkar R; Division of Pulmonary and Critical Care, University of Miami, School of Medicine, Johns Hopkins University, 1951 NW 7th Ave, Suite 2308, Miami, FL, 33136, USA.; Center for Global Non-Communicable Diseases, Johns Hopkins University, Baltimore, USA., Sekitoleko I; Makerere University Lung Institute, Makerere College of Health Sciences, Kampala, Uganda., Namazzi E; Makerere University Lung Institute, Makerere College of Health Sciences, Kampala, Uganda., Alupo P; Makerere University Lung Institute, Makerere College of Health Sciences, Kampala, Uganda., Hurst JR; UCL Respiratory, University College London, London, UK., Kalyesubula R; Department of Physiology, Makerere College of Health Sciences, Kampala, Uganda.; African Community Center for Social Sustainability, Nakaseke, Uganda., Dowdy D; Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, USA., Wise R; Division of Pulmonary and Critical Care, University of Miami, School of Medicine, Johns Hopkins University, 1951 NW 7th Ave, Suite 2308, Miami, FL, 33136, USA.; Center for Global Non-Communicable Diseases, Johns Hopkins University, Baltimore, USA., Barnes PJ; National Health and Lung Institute, Imperial College, London, UK., Checkley W; Division of Pulmonary and Critical Care, University of Miami, School of Medicine, Johns Hopkins University, 1951 NW 7th Ave, Suite 2308, Miami, FL, 33136, USA.; Center for Global Non-Communicable Diseases, Johns Hopkins University, Baltimore, USA., Kirenga B; Makerere University Lung Institute, Makerere College of Health Sciences, Kampala, Uganda.
Source: Trials [Trials] 2021 Mar 16; Vol. 22 (1), pp. 213. Date of Electronic Publication: 2021 Mar 16.
Publication Type: Clinical Trial Protocol; Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1745-6215
DOI:10.1186/s13063-021-05163-2